Condition: Carotid Artery Diseases · Aortic Diseases · Peripheral Arterial Diseases · Sponsor: Intervascular
The purpose of this registry is to evaluate the long-term safety and performance of Intervascular Vascular Grafts and Patches (Intergard Standard, Hemashield, Intergard Silver, Intergard Synergy) for bypass, repair or replacement of aortic, peripheral, or carotid arteries. This registry is intended to further define the expected product lifetime of the devices and to collect data related to usefulness of the antimicrobial coatings.
This description comes directly from the study's public registry record.
Senior Manager, Clinical Affairs · +1 603 233 7685 · kristen.nolin@getinge.com
Always discuss trial participation with your own doctor first.
| The Pennsylvania State University and The Milton S. Hershey Medical Center | Hershey, Pennsylvania, United States | Recruiting |
| Allegheny General Hospital | Pittsburgh, Pennsylvania, United States | Recruiting |
| CHU Dijon Bourgogne | Dijon, France | Recruiting |
| Hospital Universitario de Navarra | Pamplona, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07322913